Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
Geir E Tjønnfjord, Pål Andre HolmeMedical Department, Division of Hematology, Rikshospitalet- Radiumhospitalet Medical Center, Oslo, NorwayAbstract: The development of high-titer inhibitors to FVIII and less often to other coagulation factors are the most serious complication of...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2007-09-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/factor-eight-inhibitor-bypass-activity-feiba-in-the-management-of-blee-peer-reviewed-article-VHRM |